Drawing for QASKIQ

USPTO serial 79156362

QASKIQ

Reviewed by CopyMark Law Group

Reg. 4733785Status 404
Filing date
Status date
Registration date
May 12, 2015
Examiner
LEASER, ANDREW C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with QASKIQ?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system, pharmaceutical preparations for the prevention and treatment of inflammatory disorders, pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders, pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibioticsSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 8, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Sep 25, 2022GPNXNOTIFICATION PROCESSED BY IB—
May 23, 2022GPNXNOTIFICATION PROCESSED BY IB—
Feb 20, 2022DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Feb 20, 2022DETHDEATH OF INTERNATIONAL REGISTRATION—
Mar 1, 2019GPNXNOTIFICATION PROCESSED BY IB—
Jun 1, 2018DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Jun 1, 2018DETHDEATH OF INTERNATIONAL REGISTRATION—
Aug 7, 2015GPNXNOTIFICATION PROCESSED BY IB—
Jul 23, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 23, 2015FIMPFINAL DISPOSITION PROCESSED—
Jun 11, 2015GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
May 12, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 24, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 20, 2015GPNXNOTIFICATION PROCESSED BY IB—
Feb 4, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 4, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 4, 2015NPUBNOTICE OF PUBLICATION—
Jan 15, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 14, 2015DOCKASSIGNED TO EXAMINER—
Dec 20, 2014MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 16, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 12, 2014LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Dec 11, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance